BioCentury
ARTICLE | Clinical News

Oralex oral contrast agent: Began Phase II trials

October 30, 1995 8:00 AM UTC

Molecular Biosystems Inc. (MB), San Diego Product: Oralex oral contrast agent Indication: Enhance visualization of pancreas and stomach using ultrasound Status: Began Phase II trials ...